ClinicalTrials.gov record
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
ClinicalTrials.gov ID: NCT06246110
Public ClinicalTrials.gov record NCT06246110. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced May 8, 2026, 8:10 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Patients With Stage 4 Non-Small Cell Lung Cancer
Study identification
- NCT ID
- NCT06246110
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eikon Therapeutics
- Industry
- Enrollment
- 70 participants
Conditions and interventions
Conditions
Interventions
- Carboplatin Drug
- EIK1001 Drug
- Paclitaxel Drug
- Pembrolizumab Drug
- Pemetrexed Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 5, 2024
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2027
- Last update posted
- Nov 11, 2025
2024 – 2027
United States locations
- U.S. sites
- 39
- U.S. states
- 19
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern Cancer Care | Daphne | Alabama | 36608 | Recruiting |
| Ironwood Cancer and Research Center | Chandler | Arizona | 85224 | Recruiting |
| California Cancer Care Associates for Research & Excellence | Fresno | California | 93720 | Recruiting |
| California Research Institute | Los Angeles | California | 90027 | Recruiting |
| University of Southern California, Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | Recruiting |
| Providence St Joseph Hospital, Center for Cancer Prevention and Treatment | Orange | California | 92868 | Recruiting |
| Sutter Health Institute for Medical Research | Sacramento | California | 95816 | Recruiting |
| Rocky Mountain Cancer | Lone Tree | Colorado | 80124 | Recruiting |
| Bioresearch Partner | Hialeah | Florida | 33013 | Recruiting |
| Memorial Cancer Institute | Hollywood | Florida | 33021 | Recruiting |
| Mid-Florida Hematology and Oncology Center | Orange | Florida | 32763 | Recruiting |
| Orlando Health Cancer Institute | Orlando | Florida | 32806 | Recruiting |
| Moffitt Cancer Center | Tampa | Florida | 33612 | Not yet recruiting |
| Atlanta Piedmont Hospital | Atlanta | Georgia | 30318 | Not yet recruiting |
| Kaiser Permanente Hawaii | Honolulu | Hawaii | 96819 | Recruiting |
| Illinois Cancer Specialists | Niles | Illinois | 60714 | Recruiting |
| Accelacare of Duly | Tinley Park | Illinois | 60487 | Recruiting |
| Indiana University Cancer Center | Indianapolis | Indiana | 46202 | Recruiting |
| Health Midwest Oncology Associates of Kansas | Overland Park | Kansas | 66211 | Recruiting |
| Cancer Center of Kansas | Wichita | Kansas | 67214 | Recruiting |
| Medstar Franklin Square Cancer Center at Loch Raven Campus | Baltimore | Maryland | 21237 | Recruiting |
| Maryland Oncology | Columbia | Maryland | 20144 | Recruiting |
| Jersey Shore University Medical Center/Meridian Hematology & Oncology | Neptune City | New Jersey | 07753 | Recruiting |
| New York Cancer and Blood Specialists | Babylon | New York | 11702 | Recruiting |
| Laura & Isaac Perlmutter Cancer Center at NYU Langone Health | New York | New York | 10016 | Recruiting |
| Weil Cornell Medical Center | New York | New York | 10022 | Recruiting |
| Albert Einstein College of Medicine, Jacobi Medical Center | The Bronx | New York | 10461 | Recruiting |
| Cancer and Blood Specialists of New York, White Plains Hospital | White Plains | New York | 10601 | Recruiting |
| Messino Cancer Centers | Asheville | North Carolina | 28806 | Recruiting |
| Gabrail Cancer Center | Canton | Ohio | 44718 | Recruiting |
| Willamette Valley | Eugene | Oregon | 97401 | Recruiting |
| Tennessee Cancer Specialists | Knoxville | Tennessee | 37909 | Recruiting |
| Baptist Cancer Center | Memphis | Tennessee | 38120 | Recruiting |
| Texas Oncology, Austin | Austin | Texas | 78745 | Recruiting |
| Texas Oncology, Bedford | Bedford | Texas | 76022 | Recruiting |
| The Center for Cancer and Blood Disorders | Fort Worth | Texas | 76104 | Recruiting |
| Blue Ridge Cancer Care Oncology Associates SW VA | Blacksburg | Virginia | 24060 | Recruiting |
| Virginia Cancer Specialists | Fairfax | Virginia | 22031 | Recruiting |
| Shenandoah Oncology | Winchester | Virginia | 22601 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06246110, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 11, 2025 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06246110 live on ClinicalTrials.gov.